The Alzheimer Drug Discovery Foundation notes that no studies have tested whether cerebrolysin can prevent dementia in healthy individuals, and limited evidence exists for cognitive enhancement in people without existing neurological conditions
Information provided is for general lifestyle guidance only and is not medical, financial, or professional advice
GLP-1 receptor agonists are generally well tolerated, but gastrointestinal side effects are common, particularly when initiating treatment or increasing doses
Additionally, fasting can improve other health markers, including reducing levels of inflammatory markers, cholesterol, blood triglycerides, and blood pressure
Statistical analysis Data were statistically analyzed using SPSS (version 19.0.1, Chicago, Illinois, USA) for Windows